Fulgent Genetics Q1 Adj. EPS $0.04 Beats $(0.18) Estimate, Sales $73.46M Beat $71.26M Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.18) by 122.22 percent. This is a 500 percent increase over losses of $(0.01) per share from
Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.18) by 122.22 percent. This is a 500 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $73.46 million which beat the analyst consensus estimate of $71.26 million by 3.10 percent. This is a 13.92 percent increase over sales of $64.48 million the same period last year.